BioCentriq
Melissa Mastro is a seasoned professional in the field of engineering with specific expertise in manufacturing science and technology (MS&T), particularly within the biopharmaceutical sector. Currently serving as a Senior Engineer at BioCentriq, responsibilities include providing support for clinical manufacturing of drugs, ensuring technical guidance, and maintaining batch records. Previously at Celularity Inc., Melissa advanced through various roles from Laboratory Technician to Process Lead, overseeing the production of CYCART-19, and leading technology transfer for new CAR-T products. Educational qualifications include a Master of Science in Biomaterials and Tissue Engineering from UCL and a Bachelor of Science in Biomedical Engineering from The College of New Jersey.
BioCentriq
Established in 2019, BioCentriq is a full-service, New Jersey-based CDMO for cell and gene therapy, focusing on all stages of process development and clinical manufacturing. With over 90 scientists, engineers, analysts, and manufacturing specialists, we have the quality systems and infrastructure required to support the release of both autologous and allogeneic drug products. BioCentriq also specializes in viral vector process development and manufacturing with expertise in a variety of cell and vector types. Our 35,000 square feet of facilities includes four, soon to be five, ISO-7 certified GMP manufacturing suites, a fully equipped process development laboratory, quality control and analytical method development laboratories, and training facilities. We also operate the only McKinsey-owned Innovation & Learning Center designed to explore the application of industry 4.0, digital and lean manufacturing disciplines to life sciences.